UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

Pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

 

For the Month of: October 2019

 

Commission File Number: 001-37847

 

MOTIF BIO PLC

(Exact name of registrant as specified in its charter)

 

125 Park Avenue

25th Floor

New York, New York 10017

(Address of principal executive offices)

 

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ___

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ___

 

 

 

 

 

 

MOTIF BIO PLC

FORM 6-K

 

 

Change of adviser

 

On October 3, 2019, Motif Bio plc (the “Company”) issued a regulatory news service announcement stating that it appointed SP Angel Corporate Finance LLP as its nominated adviser and sole corporate broker with immediate effect. A copy of the regulatory news service announcement is attached herein as Exhibit 99.1.

 

The information contained in this report on Form 6-K, including Exhibit 99.1, is hereby incorporated by reference into the Company’s registration statements on Form F-3 (File Nos. 333-222614 and 333-222042), to be a part thereof from the date on which this report is submitted, to the extent not superseded by documents or reports subsequently filed or furnished.

 

 

Exhibits

 

Exhibit 99.1 Regulatory news service announcement issued on October 3, 2019, entitled “Change of Adviser.”

 

 

 

 

 

 

Signatures

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  MOTIF BIO PLC  
       
  By: /s/ Graham Lumsden  
  Name: Graham Lumsden  
  Title: Chief Executive Officer  

 

Date: October 3, 2019